Open-label trial to evaluate dopamine transporter occupancy in the human brain following repeated oral administration of OPC-64005 in healthy adult male subjects

Trial Profile

Open-label trial to evaluate dopamine transporter occupancy in the human brain following repeated oral administration of OPC-64005 in healthy adult male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Jun 2016

At a glance

  • Drugs OPC 64005 (Primary)
  • Indications Depression
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 14 Jun 2016 New trial record
    • 07 Apr 2016 Status changed from recruiting to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top